Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2020-12-10 | 2021-01-20 | 130021 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2023-05-19 | 2023-09-27 | 192835 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2023-09-27 | 2024-02-03 | 205330 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-01 | 2018-06-19 | 51063 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-22 | 2018-07-27 | 52770 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-08-15 | 2018-10-18 | 58228 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2020-04-20 | 2020-09-08 | 112537 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2022-09-29 | 2022-10-28 | 170488 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2024-01-24 | 2024-04-11 | 217088 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2019-10-25 | 2020-02-27 | 97281 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2020-05-05 | 2020-06-17 | 114093 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2022-09-29 | 2024-01-30 | 170485 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2017-07-27 | 2017-09-08 | 17417 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-01-09 | 2018-01-19 | 35401 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-08-28 | 2019-02-05 | 59391 |
| PATANOL | 0.1% | LIQUID | Resolved | 2018-06-01 | 2018-06-19 | 51067 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-03-26 | 2018-04-13 | 44006 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-04-27 | 2018-05-25 | 47334 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-21 | 54449 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2019-03-21 | 2019-04-18 | 79161 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| LESCOL XL | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-03-20 | 2020-04-17 | 109153 |
| VOLTAREN SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-07-10 | 2019-09-06 | 89039 |
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163678 |
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| AFINITOR | 7.5MG | TABLET | Discontinued | 2018-07-09 | 2018-07-10 | 54891 |
| SEBIVO | 600MG | TABLET | Discontinued | 2019-07-10 | 2019-11-06 | 89042 |
| LOTENSIN 5MG | 5MG | TABLET | Discontinued | 2017-07-10 | 2017-09-26 | 15053 |
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2018-01-09 | 2019-03-20 | 35419 |
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2018-01-09 | 2018-01-09 | 35425 |
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2019-04-05 | 2019-04-05 | 80614 |
| VOLTAREN | 50MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-01-08 | 2020-03-10 | 102699 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| HYCAMTIN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-26 | 2019-06-11 | 8129 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ISOPTO CARPINE | 4% | LIQUID | Discontinued | 2022-05-11 | 2022-07-14 | 160361 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-05-05 | 123894 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-09-23 | 123900 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |